A 47-year-old woman presented to the Heart Institute complaining of general weakness, chest pain, and dizziness during physical exertion. Diagnostic examinations revealed a rare pathology—a giant coronary-atrial fistula. The surgical team decided to close the fistula endovascularly using spiral systems.
What made her case unique was that she had previously undergone surgery for mitral insufficiency (with implantation of a mechanical prosthesis) and tricuspid valve repair using a ring, 10 years prior.
The Heart Institute’s team saved the lives of two young men, aged 23 and 30 from Lviv and the Lugansk region.
We want to start the new week of the new year with a phenomenal photo of our patients after heart transplantation, alongside the medical team.
The recipient in critical condition was transported by ambulance. A 46-year-old woman was so close to death that the defibrillator went off 8 times in the past day.
We are happy that we had the opportunity to join such an event, to speak before the international community, and to talk about our experience in transplant coordination, which is gaining momentum every year in Ukraine.
During the internship, our specialists took part in daily operations and gained valuable experience in performing minimally invasive interventions. They had the opportunity to take part in operations on the internal thoracic artery and mitral valve plastic surgery using the da Vinci Surgical System robot.
A 58-year-old man from the Kyiv region, who suffered from ischemic cardiomyopathy, received a new organ. The patient fought for his life for more than a year, suffered several heart attacks, and was stented. But the condition kept getting worse.
Our team has undergone important training in echocardiography, endovascular methods of prosthetic valve replacement (TAVI) and mitral insufficiency correction (mitral clip), implantation of the most modern devices to support ventricles in patients with heart failure (Impella) and participated in the newest methods of aortic pathology correction (Exovasc), heart and liver transplants.
The main purpose of the event was to discuss controversial aspects of the management of patients with heart failure, in particular, drug therapy and indications for the use of devices and cardiac surgical interventions.